Use of semaphorin 6A for promoting myelination and oligodendrocyte differentiation

Details for Australian Patent Application No. 2008214337 (hide)

Owner University Pierre and Marie Curie Biogen Idec MA Inc. Centre National de Recherche Scientifique

Inventors Mi, Sha; Bernard, Frederic; Chedotal, Alain

Agent Cullens

Pub. Number AU-B-2008214337

PCT Pub. Number WO2008/097503

Priority 60/898,992 02.02.07 US

Filing date 4 February 2008

Wipo publication date 14 August 2008

Acceptance publication date 5 July 2012

International Classifications

A61K 38/17 Medicinal preparations containing peptides - from animals

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 25/00 Drugs for disorders of the nervous system

C12N 5/079 Undifferentiated human, animal or plant cells, e.g. cell lines - Neural cells

C12N 5/0793 Undifferentiated human, animal or plant cells, e.g. cell lines - Neurons

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/097503 Priority application(s): WO2008/097503

5 July 2012 Application Accepted

  Published as AU-B-2008214337

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008214338-Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release

2008214331-Paging over a high-speed downlink shared channel